Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aralez Pharmaceuticals
Mississauga, Ontario, Canada
- Ownership
- Private
- Development stage
- Other
01
Overview
Aralez Pharmaceuticals was a global specialty pharmaceutical company formed from the merger of POZEN Inc. and Tribute Pharmaceuticals Canada Inc., focusing on acquiring, developing, and commercializing products primarily in cardiovascular and other specialty areas. The company operated across North America and Europe with an anchor position in cardiovascular disease. It discontinued U.S. commercial operations as of 2018[1][5].
- Therapeutic areas
- OtherCardiovascularNeurology
- Modalities
- Small molecules (primarily; focus on cardiovascular and pain therapies)[1][5]
- Industry
- Biotech
Beyond the preview
Go deeper on Aralez Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aralez Pharmaceuticals.